Positive results for LAV311 and LAV321 achieved in 2022 in a series of field trials, testing for protection against bunch rot, Read More
May 7, 2025
COPENHAGEN, Denmark, Feb. 28, 2023 /PRNewswire/ — DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) (“DanCann Pharma” or the “Company”), a Danish company Read More
Pune, Feb. 28, 2023 (GLOBE NEWSWIRE) — According to Market.us, the global medical tourism market accounted for USD 11.7 billion in 2022 and is Read More
Recent years have seen a relaxation of laws in multiple US states around the use of medical and non-medical cannabis, Read More
Cann Group Limited (OTCPK:CNGGF) Q2 2023 Earnings Conference Call February 27, 2023 7:00 PM ET Company Participants Matt Wright – NWR Communications Allan McCallum – Read More
Surgical patients with cannabis use disorder were linked with higher odds of a 30-day hospital readmission, compared to patients who Read More
As the years go by and the youth become the adults, weed has assimilated itself more and more into everyday Read More
LONDON, Feb. 27, 2023 /PRNewswire/ — The Global Home Diagnostics Market is anticipated to generate significant revenue over the forecast duration of 2022-2029. Read More
NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) — via CannabisNewsWire — Following numerous successful events in both North and South America, the Alternative Products Read More
Conference call scheduled for 9am ET REHOVOT, Israel, Feb. 27, 2023 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology Read More